immuno-oncology

News

Keeping up the PACE at the Scottish Medicines Consortium

Scotland backs Merck/Pfizer’s Bavencio combo for kidney canc...

The Scottish Medicines Consortium (SMC) backed NHS use of nine new medicines at its meeting this week, including Merck KGaA and Pfizer’s Bavencio as a first-line treatment for advanced kidn

News

FDA fast-tracks Leap’s gastric cancer immunotherapy

Leap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric and gastroesophageal junction (G/GEJ) cancer after being awarded fast-track status by the regula

News

FDA’s review date for BMS’ ide-cel sneaks under the CVR wire

The FDA has given a 27 March 2021 review date for Bristol-Myers Squibb’s multiple myeloma cell therapy ide-cel, just in time to meet a contingent value right (CVR) due to Celgene shareholde

News

AbbVie signs $2.9bn deal with I-Mab for ‘don’t eat me’ cance...

AbbVie has claimed rights to an immuno-oncology antibody from I-Mab in what is thought to be a record licensing deal involving a Chinese biotech.

News

BMS swoops on Forbius, snaring another immuno-oncology playe...

With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech Forbius

News

Blow for Novartis as PD-1 drug spartalizumab flunks trial

Novartis’ hopes of catching up with other companies in immuno-oncology have been dented after PD-1 inhibitor spartalizumab failed a phase 3 trial in skin cancer.

Scotland backs Merck/Pfizer’s Bavencio combo for kidney canc...

FDA fast-tracks Leap’s gastric cancer immunotherapy

FDA’s review date for BMS’ ide-cel sneaks under the CVR wire

AbbVie signs $2.9bn deal with I-Mab for ‘don’t eat me’ cance...

BMS swoops on Forbius, snaring another immuno-oncology playe...

Blow for Novartis as PD-1 drug spartalizumab flunks trial

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

immuno-oncology

Editor's Picks